SPHERA FUNDS MANAGEMENT LTD. - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,700,000
-35.6%
150,000
-86.0%
0.12%
-65.2%
Q1 2020$2,641,000
-57.5%
1,069,0890.0%0.33%
-35.5%
Q4 2019$6,211,000
+10.2%
1,069,0890.0%0.51%
-41.1%
Q3 2019$5,634,000
-12.2%
1,069,0890.0%0.87%
-0.9%
Q2 2019$6,415,000
-33.6%
1,069,0890.0%0.88%
-0.3%
Q1 2019$9,654,000
-5.6%
1,069,089
-13.2%
0.88%
-23.6%
Q4 2018$10,226,000
-35.1%
1,232,089
+7.9%
1.15%
-36.3%
Q3 2018$15,761,000
+134.1%
1,142,089
+34.8%
1.81%
+94.9%
Q2 2018$6,733,000
-11.0%
846,935
-16.1%
0.93%
-19.2%
Q1 2018$7,568,000
+6.6%
1,009,131
-3.4%
1.15%
+37.9%
Q4 2017$7,100,000
-5.6%
1,044,1310.0%0.83%
-22.4%
Q3 2017$7,518,000
+82.6%
1,044,131
+19.2%
1.07%
+53.5%
Q2 2017$4,117,000
+23.2%
875,931
+31.0%
0.70%
+6.9%
Q1 2017$3,343,000
+69.6%
668,500
+81.4%
0.65%
+31.1%
Q4 2016$1,971,000
-31.9%
368,5000.0%0.50%
+5.9%
Q3 2016$2,893,000
+38.0%
368,5000.0%0.47%
-13.4%
Q2 2016$2,097,000
+109.9%
368,500
+54.5%
0.54%
+150.7%
Q1 2016$999,000
-38.2%
238,5000.0%0.22%
-8.4%
Q4 2015$1,617,000
+4.7%
238,500
-10.0%
0.24%
+20.3%
Q3 2015$1,545,000
-24.9%
265,0000.0%0.20%
-2.0%
Q2 2015$2,056,000
+72.2%
265,000
+130.4%
0.20%
+62.1%
Q1 2015$1,194,000115,0000.12%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders